US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on Oct. 14 for "Cross-reactive epitope for multiple sclerosis" (California Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,544, issued on Oct. 14, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Cross-reactive epitope for multiple sclerosis" was invented by Naresha Saligrama (Stanford, Calif.) and Mark M. Davis (Atherton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions for diagnosis and treatment of multiple sclerosis. Compositions and methods are provided, relating to novel peptides involved in autoimmune disease. In the experiments described herein, an unbiased approach was used to screen pathogenic CD4+ T cells from patients with multiple sclerosis (MS), and to dete...